CURRENT AFFAIRS

2021

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
A
J & J
B
Corbevax
C
GSK
D
Novavax
Explanation: 

Detailed explanation-1: -Biological E Limited: Corbevax – COVID19 Vaccine Tracker. How many types of COVID-19 vaccines are there?

Detailed explanation-2: -Novavax This vaccine has reached Phase 3 trials.

Detailed explanation-3: -In phase II clinical trials, hundreds of participants are recruited. In this phase, the immunogenicity and safety of the vaccine are tested. It is important to ensure that the candidate vaccine stimulates both humoral and cellular antibody responses against the target antigen.

Detailed explanation-4: -The regulator grants full market authorisation only after it finds a vaccine safe and effective for the majority of people who have received them. The Central Drugs Standard Control Organisation’s SEC approved the market authorisation application of Biological E’s PCV on August 29.

There is 1 question to complete.